C07D 277/22
With only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to
Official title: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
C07D277/22 (With only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to) appears on 2,201 US grants and 1,966 published applications in this corpus.
Search patents in C07D- Granted patents
- 2,201
- Published applications
- 1,966
- Assignees
- 923
- Inventors
- 6,543
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 16 | 0 |
| 1977 | 30 | 0 |
| 1978 | 27 | 0 |
| 1979 | 24 | 0 |
| 1980 | 25 | 0 |
| 1981 | 22 | 0 |
| 1982 | 13 | 0 |
| 1983 | 20 | 0 |
| 1984 | 16 | 0 |
| 1985 | 9 | 0 |
| 1986 | 8 | 0 |
| 1987 | 10 | 0 |
| 1988 | 19 | 0 |
| 1989 | 21 | 0 |
| 1990 | 29 | 0 |
| 1991 | 37 | 0 |
| 1992 | 34 | 0 |
| 1993 | 49 | 0 |
| 1994 | 38 | 0 |
| 1995 | 44 | 0 |
| 1996 | 50 | 0 |
| 1997 | 66 | 0 |
| 1998 | 62 | 0 |
| 1999 | 49 | 0 |
| 2000 | 48 | 0 |
| 2001 | 61 | 18 |
| 2002 | 65 | 63 |
| 2003 | 61 | 114 |
| 2004 | 59 | 118 |
| 2005 | 57 | 112 |
| 2006 | 65 | 89 |
| 2007 | 69 | 96 |
| 2008 | 55 | 102 |
| 2009 | 60 | 104 |
| 2010 | 63 | 110 |
| 2011 | 60 | 80 |
| 2012 | 80 | 76 |
| 2013 | 69 | 78 |
| 2014 | 73 | 105 |
| 2015 | 86 | 81 |
| 2016 | 75 | 94 |
| 2017 | 64 | 70 |
| 2018 | 53 | 64 |
| 2019 | 48 | 46 |
| 2020 | 37 | 59 |
| 2021 | 31 | 48 |
| 2022 | 34 | 65 |
| 2023 | 28 | 54 |
| 2024 | 31 | 39 |
| 2025 | 31 | 50 |
| 2026 | 20 | 31 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compound and method for preventing or treating of respiratory diseases comprising the same as an active ingredient28 Jul 2026US 12,691,101 B2Yonsei University, University—Industry Foundation (Uif)
- Compounds and their uses as CD38 inhibitors14 Jul 2026US 12,679,832 B2Nanjing Immunophage Biotech Co., Ltd.
- Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof26 May 2026US 12,637,436 B2Sanford Burnham Prebys Medical Discovery Institute
- Arylamides and methods of use thereof19 May 2026US 12,630,498 B2Genzyme Corporation
- Small molecule prostagladin transport inhibitors19 May 2026US 12,630,515 B2Albert Einstein College of Medicine
- Probenecid compounds for the treatment of inflammasome-mediated lung disease8 Oct 2026US 2026/0308131 A1Bacainn Biotherapeutics, Ltd.
- Therapeutic compounds1 Oct 2026US 2026/0297016 A1Regents of the University of Minnesota
- Hdac1/2 selective inhibitor and use thereof1 Oct 2026US 2026/0297110 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Novel indenone derivatives and uses thereof3 Sep 2026US 2026/0256797 A1Amyloid Solution Inc.
- Compounds for positive modulation of the autophagy-lysosomal pathway and methods of use27 Aug 2026US 2026/0250256 A1
Most cited
By later US patents
- Phenyl heterocycles as cox-2 inhibitors281US 5,474,995 AMerck Frosst Canada, Inc. · 1995
- Phenyl heterocycles as cox-2 inhibitors208US 5,550,142 AMerck Frosst Canada, Inc. · 1996
- Phenyl heterocycles as COX-2 inhibitors204US 5,536,752 AMerck Frosst Canada, Inc. · 1996
- Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities164US 5,877,207 AAllergan Sales, Inc. · 1999
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992